Review: HIV infection and tropical parasitic diseases - Deleterious interactions in both directions?

Tropical Medicine and International Health

Volumn 7, Issue 6, 2002, Pages 479-488

  Harms, Gundel ^a   Feldmeier, Hermann ^a  

^a Institut fur Tropenmedizin   (Germany)

Author keywords

HIV; Interaction; Tropical parasitic diseases

Indexed keywords

DISEASE PREVALENCE; HUMAN IMMUNODEFICIENCY VIRUS; PARASITE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANAMNESIS; CHAGAS DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; DATA ANALYSIS; DIAGNOSTIC PROCEDURE; DISEASE COURSE; FILARIASIS; HELMINTHIASIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPATHOGENESIS; INFECTION CONTROL; LEISHMANIASIS; MALARIA; ONCHOCERCIASIS; PARASITOSIS; REVIEW; SCHISTOSOMIASIS; TH2 CELL; TROPICAL DISEASE; TRYPANOSOMIASIS; FEMALE; HEALTH; IMMUNOLOGY; MALE; PREGNANCY; PREVALENCE;

HUMAN IMMUNODEFICIENCY VIRUS; PROTOZOA; RNA VIRUSES;

FEMALE; HIV INFECTIONS; HUMANS; LEISHMANIASIS; MALARIA; MALE; PARASITIC DISEASES; PREGNANCY; PREVALENCE; SCHISTOSOMIASIS; TRYPANOSOMIASIS; WORLD HEALTH;

EID: 0036617934     PISSN: 13602276     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3156.2002.00893.x     Document Type: Review

References (116)

1. Helminth infection results in decreased virus-specific CD8+ cytotoxic T-cell and Th1 cytokine responses as well as delayed virus clearance
2. Mediterranean leishmaniasis in HIV-infected patients: Epidemiological, clinical, and diagnostic features of 22 cases
3. Human immunodeficiency virus and malaria in a representative sample of childbearing women in Kigali, Rwanda
4. Leishmania and human immunodeficiency virus co-infection: The first ten years
5. Schistosomal genital granuloma: A report of 10 cases
6. Leishmaniasis of the tongue treated with liposomal amphotericin
7. Immune activation is a dominant factor in the pathogenesis of African AIDS
8. Immune activation in the context of HIV infection
9. Concurrent infections and HIV pathogenesis
10. Ethiopian visceral leishmaniasis patients co-infected with human immunodeficiency virus
11. HIV viral load and response to antileishmanial chemotherapy in co-infected patients
12. The lipophosphoglycan of Leishmania donovani up-regulates HIV-1 transcription in T cells through the nuclear factor κB elements
13. Maternal HIV infection and infant mortality in Malawi: Evidence for increased mortality due to placental malaria infection
14. Clinical description of encephalopathic syndromes and risk factors for their occurrence and outcome and outcome during melarsoprol treatment of human African trypanosomiasis
15. Chronic immune activation associated with intestinal helminth infections results in impaired signal transduction and anergy
16. Helminths, human immunodeficiency virus and tuberculosis
17. Role of host antibody in the chemotherapeutic action of praziquantel against Schistosoma mansoni: Identification of target antigens
18. Good worms or bad worms: Do worm infections affect the epidemiological patterns of other diseases?
19. Prolonged Th2 cell activation and increased viral replication in HIV-Leishmania co-infected patients despite treatment
20. HIV/Leishmania co-infection in Portugal: Diagnosis and isoenzyme characterization of leishmania
21. Is there interaction between HIV and Plasmodium falciparum?
22. Diffuse cutaneous leishmanisis with visceral dissemination in an AIDS patient in Guadeloupe, West Indies
23. Pseudotumoral chagasic meningoencephalitis as the first manifestation of AIDS
24. Unusual cutaneous lesions in two patients with visceral leishmaniasis and HIV infection
25. Oral leishmaniasis in an HIV-positive patient caused by two different zymodemes of Leishmania infantum
26. AIDS-associated leishmaniasis: An unusual gastro-duodenal presentation
27. Leishmaniasis presenting as a dermatomyositis-like eruption in AIDS
28. Relapse of visceral leishmaniasis in patients who were co-infected with human immunodeficiency virus and who received treatment with liposomal amphotericin B
29. Liposomal amphotericin B (AmBisome) in editerranean visceral leishmaniasis: A multi-centre trial
30. Short course treatment of visceral leishmaniasis with liposomal amphotericin B (AmBisome)
31. High frequency of serious side effects from meglumine antimonate given without an upper limit dose for the treatment of visceral leishmaniasis in human immunodeficiency virus type-1-infected patients
32. Haemoculture as a tool for diagnosing visceral leishmaniasis in HIV-negative and HIV-positive patients: Interest for parasite identification
33. Global control and leishmania HIV co-infection
34. Chagasic granulomatous encephalitis in immunosuppressed patients
35. The first case of visceral leishmaniasis in a patient with HIV infection in Russia
36. Relationship between intensity of infection and immunomodulation in human schistosomiasis. I. T cell subpopulation and specific antibody response
37. Relationship between intensity of infection and immunomodulation in human schistosomiasis. II. NK cell activity and in vitro lymphocyte proliferation
38. Female genital schistosomiasis as a risk factor for the transmission of HIV
39. Female genital schistosomiasis. New challenge from a gender perspective
40. Acute fatal Trypanosoma cruzi meningoencephalitis in a human immunodeficiency virus-positive hemophilic patient
41. Reactivation of Chagas' disease in patients with AIDS: A report of three new cases and a review of the literature
42. HIV/AIDS, helminths and eosinophilia. HIV and AIDS
43. Onchocerciasis and HIV in Western Uganda: Prevalences and treatment with ivermectin
44. Malaria infection induces virus expression in human immunodeficiency virus transgenic mice by CD4 T-cell-dependent immune activation
45. Numerical and functional alterations of lymphocytes in human schistosomiasis
46. Two cases of laryngeal leishmaniasis in patients infected with HIV
47. Filarial infections increase susceptibility to human immunoficiency virus infection in peripheral blood mononuclear cells in vitro
48. Treatment of Mediterranean visceral leishmaniasis
49. Laryngeal leishmaniasis
50. Nasal leishmaniasis in an HIV-positive patient
51. Natural killer cell activity in visceral leishmaniasis
52. Female genital schistosomiasis (FGS): Relationship between gynecological and histopathological findings
53. The effect of Plasmodium falciparum malaria on HIV-1 RNA blood plasma concentration
54. Decreased CD4 and increased CD8 counts with T cell activation is associated with chronic helminth infection
55. Studies on schistosomiasis in western Kenya. I. Evidence for immune-facilitated excretion of schistosome eggs from patients with Schistosoma mansoni and human immunodeficiency virus co-infection
56. Studies on schistosomiasis in western Kenya. II. Efficacy of praziquantel for treatment of schistosomiasis in persons coinfected with HIV-1
57. Visceral leishmaniasis in patients infected with the human immunodeficiency virus
58. Treatment of visceral leishmaniasis in HIV-infected patients: A randomised trial comparing meglumine antimonate with amphotericin B
59. Chagasic meningoencephalitis in the immunodeficient
60. Genital schistosomiasis in males - A community-based study from Madagascar
61. Clinicoepidemiologic characteristics, prognostic factors, and survival analysis of patients co-infected with human immunodeficiency virus and Leishmania in an area of Madrid, Spain
62. Absence of epidemiological inter-relations between HIV infection and African human trypanosomiasis in central Africa
63. Interaction between HIV infection and other sexually transmitted diseases
64. Helminth- and Bacillus Calmette-Guérin-induced immunity in children sensitized in utero to filariasis and schistosomiasis
65. Worms and pediatric human immunodeficiency virus infection and tuberculosis
66. American cutaneous leishmaniasis associated with HIV infection: Report of four cases
67. Human immunodeficiency virus infection and human African trypanosomiasis: A case-control study in Cote d'Ivoire
68. The role of serology in the diagnosis and prognosis of visceral leishmaniasis in patients coinfected with HIV type-1
69. Mucocutaneous leishmaniasis and HIV
70. Immunity to placental malaria. I. Elevated production of IFN-gamma by placental blood mononuclear cells is associated with protection in a high transmission area
71. Immunity to placental malaria. II. Placental antigen-specific cytokine responses are impaired in human immunodeficiency virus-infected women
72. Pleural and peritoneal leishmaniasis in an AIDS patient
73. Absence of association between Plasmodium falciparum and human immunodeficiency virus infection in children in Kinshasa, Zaire
74. Absence of relationship between human immunodeficiency virus 1 and sleeping sickness
75. Chagas' disease and HIV co-infection: Genotypic characterisation of the Trypanosoma cruzi strain
76. Efficacy of sulfadoxinepyrimethamine for prevention of placental malaria in an area of Kenya with high prevalence of malaria and human immunodeficiency virus infection
77. The impact of immunodeficiency virus infection on the epidemiology and treatment of Trypanosoma brucei gambiense sleeping sickness in Nioko, Zaire
78. Anal ulcer and chronic diarrhoea as manifestation of visceral leishmaniasis in a patient infected with human immunodeficiency virus
79. Clinical analysis and parasite genetic diversity in human immunodeficiency virus/Chagas disease coinfection in Brazil
80. Visceral leishmaniasis in HIV-infected and non-HIV-infected patients. A comparative study
81. Role of PCR diagnosis and prognosis of visceral leishmaniasis in patients coinfected with human immunodeficiency virus type 1
82. Schistosomiasis of the female genital tract: Public health aspects
83. Female genital schistosomiasis of the lower reproductive tract: Prevalence and schistosome-related morbidity
84. The Th1/Th2 paradigm
85. Fatal meningoencephalitis caused by reactivation of Trypanosoma cruzi infection in a patient with AIDS
86. Rectal leishmaniasis in a patient with AIDS
87. Clinical manifestation of visceral leishmaniasis associated with HIV-infection: A retrospective study of 91 French cases
88. HIV and Leishmania coinfection: A review of 91 cases with focus on atypical locations of Leishmania
89. Declining incidence of visceral leishmaniasis in HIV-infected individuals in the highly active antiretroviral therapy
90. Visceral leishmaniasis in HIV infected patients: Treatment with high dose liposomal amphotericin B (AmBisome)
91. Schistosoma mansoni: Reduced efficacy of chemotherapy in infected T-cell deprived mice
92. Reactivation of Chagas' disease in a human immunodeficiency infected patient leading to severe heart disease with late positive direct microscopic examination of the blood
93. Follow-up of 18 patients with human immunodeficiency virus infection and chronic Chagas'disease, with reactivation of Chagas' disease causing cardiac disease in three patients
94. T cell responses in coinfection with Onchocerca volvulus and the human immunodeficiency virus type 1
95. Increased susceptibility to HIV-1 infection of peripheral blood mononuclear cells from chronically immuno-activated individuals
96. Role of T-cell derived cytokines in the downregulation of immune responses in parasitic and retroviral infection
97. American cutaneous leishmaniasis due to Leishmania guyanensis as an initial clinical presentation of human immunodeficiency virus infection
98. Malaria parasites infection during pregnancy and at delivery in mother, placenta and newborn: Efficacy of chloroqine and mefloquine in rural Malawi
99. Impairment of a pregnant woman's acquired ability to limit Plasmodium falciparum by infection with human immunodeficiency virus type-1
100. Childhood malaria parasitaemia and human immunodeficiency virus infection in Malawi
101. Impaired antibody responses and loss of reactivity to Onchocerca volvulus antigens by HIV-seronegative onchocerciasis patients
102. Can HIV-1 infections in Africa provide insights into acquired immunity to malaria?
103. Highly active antiretroviral therapy decreases the incidence of visceral leishmaniasis in HIV-infected individuals
104. Increased prevalence of malaria in HIV-infected pregnant women and its implications for malaria control
105. HIV-1 infection and malaria parasitaemia
106. Prospective evaluation and follow-up of European patients with visceral leishmaniasis and HIV-1 coinfection in the era of highly active antiretroviral therapy
107. Immunoregulation within the granulomas of murine schistosomiasis mansoni
108. Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda. A cohort study
109. Leishmania/HIV co-infection, south-western Europe 1990-1998
110. Chagas disease
111. Leishmania-HIV-interaction: Immunopathogenic mechanisms
112. Plasmodium falciparum antigen-induced human immunodeficiency virus type 1 replication is mediated through induction of tumor necrosis factor alpha
113. T cell phenotype alterations in hepatosplenic schistosomiasis mansoni normalize after chemotherapy
114. Release of interleukin 2 and gamma interferon by peripheral mononuclear cells in human Schistosoma mansoni infection normalizes after chemotherapy
115. Determinants of the immune response in visceral leishmaniasis: Evidence for predominance of endogenous interleukin 4 over interferon-alpha production